Launch One Acquisition Corp.

Launch One Acquisition Corp. reported a net income of $1.60 million for Q2 2026, a decrease from $1.92 million in Q2 2025. The company announced the termination of its Business Combination Agreement with Minovia Therapeutics Ltd. on January 30, 2026, and is now seeking alternative business combination opportunities. Management has raised substantial doubt about the company's ability to continue as a going concern, citing its liquidity condition and the mandatory liquidation date of January 15, 2027, if a business combination is not completed.

Launch One Acquisition Corp. shareholders approved an extension of the deadline to complete a business combination from July 15, 2026, to January 15, 2027. This approval was secured at an extraordinary general meeting. The company also entered into Non-Redemption Agreements with investors covering 1,650,000 Class A ordinary shares, where the sponsor agreed to transfer 330,000 Class A ordinary shares to these investors to incentivize them not to redeem their shares and to vote in favor of the extension.

Launch One Acquisition Corp. issued 5,749,999 Class A ordinary shares to its Sponsor upon conversion of Class B shares, resulting in 28,749,999 Class A shares outstanding. The company is also seeking shareholder approval to extend its deadline for a business combination from July 15, 2026, to January 15, 2027. To facilitate this, the Company and Sponsor intend to enter into non-redemption agreements with shareholders, where investors agree not to redeem their Class A shares and to vote for the extension in exchange for the Sponsor transferring Class A shares to them after the business combination.

Launch One Acquisition Corp. has postponed its extraordinary general meeting, originally scheduled for July 7, 2026, to July 10, 2026, at 10:00 a.m. Eastern Time. The primary purpose of the meeting is to vote on an amendment to extend the deadline for the company to complete an initial business combination from July 15, 2026, to January 15, 2027. The deadline for shareholders to exercise their redemption rights has also been extended to July 8, 2026.

Launch One Acquisition Corp. (LPAA) has filed a definitive proxy statement for an extraordinary general meeting (EGM) to be held on July 7, 2026. The primary purpose is to vote on extending the deadline to complete a business combination from July 15, 2026, to January 15, 2027. Shareholders will have the option to redeem their shares if the extension is approved. The meeting will also include a proposal to ratify WithumSmith+Brown, PC as the independent auditor for 2026 and a proposal to adjourn the meeting if needed. The company currently has approximately $249 million in its trust account, with an anticipated redemption price of $10.83 per share.

Launch One Acquisition Corp. announced the appointment of Daniel Clifford Rogers to its Board of Directors, effective June 2, 2026. Mr. Rogers replaces Dr. Risa Stack, who resigned from the Board and as chairperson of the Audit Committee. Mr. Rogers will also serve as the new chair of the Audit Committee and as a member of the second class of directors. Dr. Stack's resignation was not due to any disagreement with the company.

Launch One Acquisition Corp. announced the termination of its Business Combination Agreement with Minovia Therapeutics Ltd. on January 30, 2026, and is now actively seeking an alternative business combination. The company reported a net income of $1,700,072 for the three months ended March 31, 2026, a decrease from $2,287,413 in the prior year period, alongside increased general and administrative expenses. Management has identified substantial doubt about the company's ability to continue as a going concern due to its liquidity condition and the approaching mandatory liquidation date of July 15, 2026, if a business combination is not completed.